These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29293)

  • 1. Gaucher disease: isolation and comparison of normal and mutant glucocerebrosidase from human spleen tissue.
    Pentchev PG; Brady RO; Blair HE; Britton DE; Sorrell SH
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3970-3. PubMed ID: 29293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study on glucocerebrosidase in spleens from patients with Gaucher disease.
    Aerts JM; Donker-Koopman WE; Brul S; Van Weely S; Sa Miranda MC; Barranger JA; Tager JM; Schram AW
    Biochem J; 1990 Jul; 269(1):93-100. PubMed ID: 2198026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of heat-stable glucocerebrosidase activators from the spleens of three variants of Gaucher's disease.
    Peters SP; Coffee CJ; Glew RH; Lee RE; Wenger DA; Li SC; Li YT
    Arch Biochem Biophys; 1977 Sep; 183(1):290-7. PubMed ID: 907355
    [No Abstract]   [Full Text] [Related]  

  • 4. [Properties of the molecular forms of beta-glucosidase and beta-glucocerebrosidase from normal human and Gaucher disease spleen (author's transl)].
    Maret A; Salvayre R; Negre A; Douste-Blazy L
    Eur J Biochem; 1981 Apr; 115(3):455-61. PubMed ID: 6786882
    [No Abstract]   [Full Text] [Related]  

  • 5. The assay of glucocerebrosidase activity using the natural substrata.
    Strasberg PM; Lowden JA
    Clin Chim Acta; 1982 Jan; 118(1):9-20. PubMed ID: 7053909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcellular localization of the heat-stable glucocerebrosidase activator substance in Gaucher spleen.
    Chiao YB; Chambers JP; Glew RH; Lee RE; Wenger DA
    Arch Biochem Biophys; 1978 Feb; 186(1):42-51. PubMed ID: 629536
    [No Abstract]   [Full Text] [Related]  

  • 7. Conditions affecting the activity of glucocerebrosidase purified from spleens of control subjects and patients with type 1 Gaucher disease.
    Aerts JM; Sa Miranda MC; Brouwer-Kelder EM; Van Weely S; Barranger JA; Tager JM
    Biochim Biophys Acta; 1990 Oct; 1041(1):55-63. PubMed ID: 2223847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and properties of a heat-stable glucocerebrosidase activating factor from control and Gaucher spleen.
    Peters SP; Coyle P; Coffee CJ; Glew RH
    J Biol Chem; 1977 Jan; 252(2):563-73. PubMed ID: 13071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological and catalytic quantitation of splenic glucocerebrosidase from the three clinical forms of Gaucher disease.
    Pentchev PG; Neumeyer B; Svennerholm L; Groth CG; Brady RO
    Am J Hum Genet; 1983 Jul; 35(4):621-8. PubMed ID: 6881138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gaucher disease: the effects of phosphatidylserine on glucocerebrosidase from normal and Gaucher fibroblasts.
    Choy FY
    Hum Genet; 1984; 67(4):432-6. PubMed ID: 6436168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of human spleen glucocerebrosidases by monoacylglycol sulfates and diacylglycerol sulfates.
    Gonzales ML; Basu A; de Haas GH; Dijkman R; van Oort MG; Okolo AA; Glew RH
    Arch Biochem Biophys; 1988 Apr; 262(1):345-53. PubMed ID: 3355173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A kinetic study of the effects of galactocerebroside 3-sulphate on human spleen glucocerebrosidase. Evidence for two activator-binding sites.
    Prence EM; Garrett KO; Glew RH
    Biochem J; 1986 Aug; 237(3):655-62. PubMed ID: 3800908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of beta-glucocerebrosidase from beta-glucosidase in human tissues using sodium taurocholate.
    Peters SP; Coyle P; Glew RH
    Arch Biochem Biophys; 1976 Aug; 175(2):569-82. PubMed ID: 958319
    [No Abstract]   [Full Text] [Related]  

  • 14. Gaucher disease: comparative study of acid phosphatase and glucocerebrosidase in normal and type-1 Gaucher tissues.
    Choy FY
    Am J Med Genet; 1985 Jul; 21(3):519-28. PubMed ID: 4025386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The enzymatic defect in Gaucher disease.
    Brady RO
    Prog Clin Biol Res; 1982; 95():309-14. PubMed ID: 7122638
    [No Abstract]   [Full Text] [Related]  

  • 16. High-resolution proton nuclear magnetic resonance studies of the glucocerebrosidase activator protein from Gaucher spleen.
    Sheh L; Glew RH; Bothner-By AA; Mishra PK
    Biochemistry; 1985 Nov; 24(23):6645-51. PubMed ID: 4084549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activators of spleen glucocerebrosidase from controls and patients with various forms of Gaucher's disease.
    Basu A; Glew RH; Daniels LB; Clark LS
    J Biol Chem; 1984 Feb; 259(3):1714-9. PubMed ID: 6693432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of a heat-stable factor in human spleen on glucocerebrosidase and acid -glucosidase activities.
    Pentchev PG; Brady RO
    Biochim Biophys Acta; 1973 Feb; 297(2):491-6. PubMed ID: 4705477
    [No Abstract]   [Full Text] [Related]  

  • 19. Further studies on the activation of glucocerebrosidase by a heat-stable factor from Gaucher spleen.
    Prence E; Chakravorti S; Basu A; Clark LS; Glew RH; Chambers JA
    Arch Biochem Biophys; 1985 Jan; 236(1):98-109. PubMed ID: 3966805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfogalactocerebroside and bis-(monoacylglyceryl)-phosphate as activators of spleen glucocerebrosidase.
    Prence EM; Garrett KO; Panitch H; Basu A; Glew RH; Wherrett JR; Huterer S
    Clin Chim Acta; 1986 Apr; 156(2):179-89. PubMed ID: 3085988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.